Basaglar ‘Copycat’ Insulin for Diabetes Has Advantages Over Lantus Uncategorized / June 13, 2022 Real-world study confirms Basaglar is as safe and effective in type 2 diabetes as Lantus, both formulations of insulin glargine, but the former was cheaper and had better adherence. Medscape Medical News